Nicola Evans Selected Research

Hepatomegaly

1/2021

Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Evans Research Topics

Disease

2	Birth Weight (Birth Weights) 01/2024 - 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2024
1	Cognitive Dysfunction 01/2022
1	Frailty 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hypertrophy 01/2022
1	Weight Loss (Weight Reduction) 11/2021
1	Delayed Puberty 11/2021
1	Gestational Weight Gain 01/2021
1	Hepatomegaly 01/2021

Drug/Important Bio-Agent (IBA)

3	ammonium 2,3,3,3- tetrafluoro- 2- (heptafluoropropoxy)- propanoateIBA 01/2024 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2021
2	Liver GlycogenIBA 01/2024 - 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	LipidsIBA 01/2022
1	CholesterolIBA 01/2022
1	GlycogenIBA 01/2022
1	Thyroid HormonesIBA 01/2022
1	Testosterone (Sustanon)FDA Link 11/2021

Therapy/Procedure

1	Transplantation 01/2022
1	Kidney Transplantation 01/2022